- Home
- KALV vs SCSC Comparison
KALV vs SCSC Comparison
Compare KALV & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- SCSC
- Stock Information
- Founded
- KALV N/A
- SCSC 1992
- Country
- KALV United States
- SCSC United States
- Employees
- KALV N/A
- SCSC N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- SCSC Retail: Computer Software & Peripheral Equipment
- Sector
- KALV Health Care
- SCSC Technology
- Exchange
- KALV Nasdaq
- SCSC Nasdaq
- Market Cap
- KALV 642.3M
- SCSC 732.8M
- IPO Year
- KALV N/A
- SCSC 1994
- Fundamental
- Price
- KALV $11.41
- SCSC $41.81
- Analyst Decision
- KALV Strong Buy
- SCSC Hold
- Analyst Count
- KALV 8
- SCSC 1
- Target Price
- KALV $24.83
- SCSC N/A
- AVG Volume (30 Days)
- KALV 1.1M
- SCSC 193.1K
- Earning Date
- KALV 07-10-2025
- SCSC 05-08-2025
- Dividend Yield
- KALV N/A
- SCSC N/A
- EPS Growth
- KALV N/A
- SCSC N/A
- EPS
- KALV N/A
- SCSC 2.78
- Revenue
- KALV N/A
- SCSC $2,974,037,000.00
- Revenue This Year
- KALV N/A
- SCSC N/A
- Revenue Next Year
- KALV N/A
- SCSC $4.96
- P/E Ratio
- KALV N/A
- SCSC $15.11
- Revenue Growth
- KALV N/A
- SCSC N/A
- 52 Week Low
- KALV $7.30
- SCSC $28.75
- 52 Week High
- KALV $15.50
- SCSC $53.90
- Technical
- Relative Strength Index (RSI)
- KALV 37.30
- SCSC 61.04
- Support Level
- KALV $11.10
- SCSC $41.39
- Resistance Level
- KALV $12.63
- SCSC $42.37
- Average True Range (ATR)
- KALV 0.89
- SCSC 0.96
- MACD
- KALV -0.23
- SCSC -0.09
- Stochastic Oscillator
- KALV 31.35
- SCSC 69.08
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.